Advertisement

Topics

FDA outlines efforts to reduce orphan drug designation backlog

16:21 EDT 29 Jun 2017 | Drug Store News

The agency has outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.

read more

Original Article: FDA outlines efforts to reduce orphan drug designation backlog

NEXT ARTICLE

More From BioPortfolio on "FDA outlines efforts to reduce orphan drug designation backlog"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...